Related Experiment Video
Updated: Nov 17, 2025

08:18
Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
17.6K
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics
Dingyu Hu1, Shunling Yuan1, Jing Zhong2
1Department of Clinical Laboratory, The First Affiliated Hospital, University of South China, Hengyang 421001, Hunan, China.
Pharmacology & Therapeutics
|February 15, 2021
Summary
Cellular senescence, a cell cycle arrest, plays a dual role in cancer, preventing and promoting tumor growth. Targeting senescence offers new therapeutic strategies for hematological malignancies.
Area of Science:
- Oncology
- Cell Biology
- Hematology
Background:
- Cellular senescence is a permanent cell cycle arrest induced by stress.
- It plays a complex role in tumorigenesis, potentially preventing or promoting cancer.
- Cellular senescence is implicated in hematological malignancies like leukemia, MDS, and MM.
Purpose of the Study:
- To review the role of cellular senescence in the pathogenesis and development of hematological malignancies.
- To explore potential therapeutic strategies targeting cellular senescence in these diseases.
- To summarize emerging information on cellular senescence in tumorigenesis and clinical applications.
Main Methods:
- Systematic review of existing literature.
- Analysis of the role of cellular senescence in hematological malignancies.
- Investigation of the bone marrow microenvironment's influence.
Main Results:
- Cellular senescence is linked to hematopoietic stem cell decline and increased malignancy risk.
- The senescence-associated secretory phenotype (SASP) in the bone marrow microenvironment promotes tumor growth.
- Therapeutic strategies targeting senescence, including induction and elimination, are being developed.
Conclusions:
- Cellular senescence is a critical factor in hematological malignancies.
- Targeting cellular senescence presents promising therapeutic avenues.
- Understanding senescence mechanisms can guide rational treatment design for these cancers.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Hematopoiesis
7.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.7K
Replicative Cell Senescence
4.0K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.0K
Multipotency of Hematopoietic Stem Cells
3.6K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K
Aging
424
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
424
Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K

